Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients

Fig. 5

Bar plots showing the metabolic activity of drug-induced glial cells and cytotoxicity of memantine, parbendazole and bortezomib at different doses based on MTT assay and LDH release assay, after drug treatment on Day 2. A significant change in cell viability percentage representing metabolic activity compared to control or OD absorbance at 450 nm representing lysed cells compared to negative control is indicated by the * sign

Back to article page